• Biologic and Cell Solutions
    • Unlock Enhanced Efficacy with Your Biologic Therapies
  • For Partners
    • Improving Existing Therapies
    • Develop New Therapies
  • The Science
    • Core Shell Spherification
    • Microencapsulation and Cell Therapies
    • 50+ Unique Formulations
    • ViscoBeads
  • About Us
    • Our Story
    • Innovation
    • Our Team
    • Bio-Blog
    • Publications
    • Events
    • Careers
    • Press Release
  • Contact Us

Nick Ogden

Axio BioPharma and Likarda Announce Strategic Partnership to Accelerate Biologic Drug Development and Delivery

June 9, 2025 by Nick Ogden
Categories Press Release

Microencapsulation of Liver Spheroids with Poly(Vinyl Alcohol) Enhances Function Compared with Alginate

April 23, 2025April 22, 2025 by Nick Ogden

View the article

Categories Publications

An Exciting Breakthrough in Liver Cell Therapy

April 23, 2025April 22, 2025 by Nick Ogden
Likarda promo: "Exciting Breakthrough in Liver Cell Therapy." Read about their tissue engineering study. Glowing green liver cells shown.
Categories Press Release

Likarda Receives Grant to Deliver Antibody-Secreting Cell Therapy with CSS® Hydrogel Encapsulation

March 12, 2025March 12, 2025 by Nick Ogden
Announcement - Likarda Receives Grant to Deliver Antibody-Secreting Cell Therapy with CSS® Hydrogel Encapsulation
Categories Press Release

Likarda Partners with VitalTE to Develop Extended-Release Injectable Hormone Therapies

December 11, 2024 by Nick Ogden
Likarda Partners With VitalTE to Develop Extended-Release Injectable Hormone Therapies
Categories Press Release

Is Controlled Delivery the Future of Biologics?

October 14, 2024October 10, 2024 by Nick Ogden
Categories Cell Therapy

Likarda appoints Shelly Adams as Chief Commercial Officer

April 17, 2024 by Nick Ogden
Shelly Adams, Chief Commercial Officer
Categories Press Release

Stem Cells: From Research to Cures

April 15, 2024April 15, 2024 by Nick Ogden
Categories Cell Therapy

Characterization of Hydrogel Carriers: Improving the Efficacy of Existing Cell Therapies

April 24, 2024April 10, 2024 by Nick Ogden

View the article

Categories Publications

Reduction of Activin A Gives Rise to Comparable Expression of Key Definitive Endoderm and Mature Beta Cell Markers

March 21, 2024January 19, 2024 by Nick Ogden

View the article

Categories Publications
Older posts
Page1 Page2 Page3 Next →

816 605 6440

Solutions

For Partners

The Science

Our Team

Publications

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow

© 2023 Likarda      All Rights Reserved     Terms and Conditions      Privacy Policy      |      Website Crafted by MESH Interactive

Manage Cookie Consent
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember...and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Policy
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}